Many Opioid Users With Mental Illness Lack Treatment

Many Opioid Users With Mental Illness Lack Treatment

Bookmark and Share


A significant portion of opioid abusers have unmet needs for mental health care, UMD researchers report.(Illustration by iStock)
A significant portion of opioid abusers have unmet needs for mental health care, UMD researchers report.
(Illustration by iStock)

Many people suffering from both opioid use and mental health disorders receive treatment for neither, despite a significant proportion reporting unmet mental health needs, according to a new University of Maryland-led study.

Postdoctoral associate Priscilla Novak and Associate Professor Jie Chen from the UMD School of Public Health, along with researchers from Johns Hopkins University and the U.S. Department of Health and Human Services, investigated how the combination of mental illness and opioid use disorder (OUD) affects the treatment of both issues. Their findings are published in the March issue of the Journal of Substance Abuse Treatment.

Using data from a nationally representative survey, the researchers found that 47 percent of those suffering from both OUD and mild to moderate mental illness were not receiving care for either issue. Of those with serious mental illness and OUD, 21 percent got no treatment.

“The results suggest that there is room for much improvement in coordination of substance use disorder and mental health treatment,” the study notes. The research is part of Chen’s Hospital and Public Health Interdisciplinary Research Lab, which studies system-level care coordination among hospitals, communities and public health agencies that can improve population mental health and reduce health disparities.

Despite the availability of some services, many of the individuals surveyed who had OUD still had unmet need for mental health treatment—30 percent of those with mild or moderate mental health disorders and 60 percent with serious mental illness.

More than half of patients reported affordability as a barrier to care, often because their insurance wouldn’t cover enough of the cost. Many patients also said they feared the stigma associated with treatment.

Among those receiving mental health care, the most popular form of treatment was prescription medication. Yet psychotropic medications can present problems for those with opioid use disorder, such as heightening the effects of opioid use and making lower doses more potent, the study reports.

 
This article originally appeared in Maryland Today.

February 4, 2019


Prev   Next

Current Headlines

UMD Researchers Win $1.5M Minerva Grant to Understand Social Media Information Campaigns

UMD Division of Research Announces Maryland Catalyst Fund New Direction 2019 Award Winners

UMD’s Julie Lenzer Authors Article in the National Academy of Inventors journal, Technology and Innovation

Maryland Energy Innovation Institute Launches First Start-Up in Incubator

Scientists Identify New Genetic Interactions that May Impact Cancer Outcomes

UMD BRAKE Research Administration Training Team Delivers Workshops in Ireland

UMD Physicist for Apollo Experiment Gets Chance to Send Next Gen Version to Moon

Mellon Foundation Awards $2.8M for Research, Digitization in Humanities

News Resources

Return to Newsroom

Search News

Archived News

Events Resources

Events Calendar

Additional Resources

UM Newsdesk

Faculty Experts

Connect

social iconsFacebookTwitterLinkedInResearch News RSS Feed
Office of Technology Commercialization
2130 Mitchell Building
7999 Regents Dr.
University of Maryland
College Park, MD 20742

Phone: 301-405-3947  |  Fax: 301-314-9502
Email: umdtechtransfer@umd.edu

© Copyright 2013 University of Maryland

Did You Know

UMD's Neutral Buoyancy Research Facility, which simulates weightlessness, is one of only two such facilities in the U.S.